High Plasma Levels of Neopterin Are Associated with Increased Mortality among Children with Severe Malaria in Benin
Authors:
- Samuel Odarkwei BlanksonSBSamuel Odarkwei Blankson
- Lauriane RietmeyerLRLauriane Rietmeyer
- Patrick TetteyPTPatrick Tettey
- Liliane DikrohLDLiliane Dikroh
- Bernard TornyigahBTBernard Tornyigah
- Rafiou AdamouRARafiou Adamou
- Azizath MoussiliouAMAzizath Moussiliou
- Caroline PadounouCPCaroline Padounou
- Annick AmoussouAAAnnick Amoussou
- Benedicta Ayiedu MensahBMBenedicta Ayiedu Mensah
- Maroufou J. AlaoMAMaroufou J. Alao
- Gordon AwandareGAGordon Awandare
Open Access
- 31 January 2023
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 13 (3) , 528
Abstract
Among the barriers to accessing adequate treatment and high-level monitoring for malaria febrile patients is the lack of effective prognostic markers. Neopterin, which is a marker of monocyte/macrophage activation, was found have increased during severe malaria. In this study, we used quantitative ELISA in order to assess the levels of plasma soluble neopterin in 151 patients from a cohort of Beninese children with severe malaria. We evaluated the prognostic accuracy of this molecule in order to predict the outcome of the disease. Our results show that neopterin levels were not significantly different between patients with different forms of severe malaria, including severe non-cerebral malaria (SNCM) and cerebral malaria (CM). However, the levels of this molecule were found to be higher in patients with severe malarial anemia (SMA) among both CM and SNCM cases (p-value = 0.02). Additionally, the levels of this molecule were found to be higher in patients who died from these pathologies compared to those who survived among the two clinical groups (p-value < 0.0001) and within the same group (p-value < 0.0001 for the CM group, p-value = 0.0046 for the SNCM group). The AUC-ROC for fatality among all the severe cases was 0.77 with a 95%CI of (0.69–0.85). These results suggest that plasma neopterin levels constitute a potential biomarker for predicting fatality among severe falciparum malaria patients.Keywords
Funding Information
- Institut Mérieux at Lyon France (G74882-2017)
- Institut de Recherche pour le Développement (IRD) (G74882-2017)
- SCAC—Cultural and Cooperation Department—French Embassy (G74882-2017)
- Scholarship Secretariat Ghana (G74882-2017)
- The Danish International Development Agency (DANIDA) (G74882-2017)
This publication has 52 references indexed in Scilit:
- Predicting the Clinical Outcome of Severe Falciparum Malaria in African Children: Findings From a Large Randomized TrialClinical Infectious Diseases, 2012
- Neopterin and procalcitonin are suitable biomarkers for exclusion of severe Plasmodium falciparum disease at the initial clinical assessment of travellers with imported malariaMalaria Journal, 2010
- How do red blood cells cause hypoxic vasodilation? The SNO-hemoglobin paradigmAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Neopterin in HIV-1 infectionMolecular Immunology, 2005
- Predictive Value of Urinary Neopterin in Patients with Lung CancerClinical Chemistry and Laboratory Medicine (CCLM), 1995
- Neopterin Levels in Plasma during a Longitudinal Study in an Area Endemic for MalariaClinical Immunology and Immunopathology, 1993
- Effect of pteridine derivatives on intracellular calcium concentration in human monocytic cellsFEBS Letters, 1993
- Proposed link between cytokines, nitric oxide and human cerebral malariaParasitology Today, 1991
- Biopterin and neopterin in human salivaLife Sciences, 1989
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.Journal of Experimental Medicine, 1984